VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AKTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AKTXAkari Therapeutics, Plc
$9.69$203878
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAKTXQuarterly Financials

Akari Therapeutics, Plc (AKTX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Akari Therapeutics, Plc (AKTX) quarterly income statement — complete revenue, gross profit & net income history

AKTX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold0000000013K00000000000
COGS % of Revenue--------------------
Gross Profit00000000-13K00000000000
Gross Margin %--------------------
Gross Profit Growth %----100%---------------
Operating Expenses15.76M3.23M7.4M3.12M3.52M5.28M2.93M7.45M5.98M5.09M2.51M4.62M4.59M6.01M6.01M5.82M5.24M5.87M1.46M4.33M
OpEx % of Revenue--------------------
Selling, General & Admin2.17M2.14M1.98M2.45M2.71M3.05M1.71M2.24M3.7M2.58M2.82M3.09M2.86M3.73M3.73M2.97M3.1M2.02M1.89M2.15M
SG&A % of Revenue--------------------
Research & Development1.46M1.09M249K667K813K1.25M143K3.31M2.28M5.08M-314K1.52M1.73M3.44M3.44M2.85M2.14M6.92M-430.16K2.18M
R&D % of Revenue--------------------
Other Operating Expenses1000K-1.5K1000K00983K1000K1000K-2-1000K000-1000K-1000K00-1000K00
Operating Income-15.76M-3.23M-7.4M-3.12M-3.52M-5.28M-2.93M-7.45M-5.99M-5.09M-2.51M-4.62M-4.59M-6.01M-6.01M-5.82M-5.24M-5.87M-1.46M-4.33M
Operating Margin %--------------------
Operating Income Growth %-347.04%38.86%-152.96%58.13%41.14%-3.69%-16.75%-61.41%-30.37%15.36%58.31%20.65%12.39%-2.42%-310.96%-34.32%5.49%14.84%-492.75%26.75%
EBITDA-15.25M-4.49M-7.37M-1.84M-3.65M-5.28M-2.83M-7.51M-5.98M-5.09M-2.51M-4.61M-4.59M-6.01M-6.01M-5.82M-5.24M-5.87M-1.46M-4.33M
EBITDA Margin %--------------------
EBITDA Growth %-317.89%14.91%-160.69%75.42%38.92%-3.69%-12.77%-62.7%-30.11%15.37%58.32%20.66%12.4%-2.42%-311.18%-34.33%5.49%14.84%-494.71%26.73%
D&A (Non-Cash Add-back)000001K0013K1K1K1K1K1.03K1.03K9421.01K1.01K1.03K1.05K
EBIT-15.25M-4.49M-7.37M-1.84M-3.65M-3.65M-2.83M-7.51M-5.99M-5.09M-2.87M-4M-4.59M-6.01M-6.01M-5.82M-5.24M-5.87M-1.46M-4.33M
Net Interest Income-61K-723K-119.28K-50K-55K-123K-66K-49K2K11029K30K19193.96K4.36K3.98K1.37K1.51K
Interest Income00994001K3K2K2K11029K30K19193.96K4.36K3.98K1.37K1.51K
Interest Expense61K723K120.27K50K55K124K69K51K000000000000
Other Income/Expense444K-1.99M-84K1.22M-180K1.51M32K-109K423K952K-364K615K5.59M2.57M2.57M136.17K67.59K84.02K12.04K-16.33K
Pretax Income-15.31M-5.21M-7.49M-1.9M-3.71M-3.77M-2.9M-7.56M-5.57M-4.14M-2.87M-4M1M-3.45M-3.45M-5.68M-5.18M-5.79M-1.45M-4.35M
Pretax Margin %--------------------
Income Tax-859K85K-1.09M00000000000000000
Effective Tax Rate %5.61%-1.63%14.53%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-14.46M-5.3M-6.4M-1.9M-3.71M-3.77M-2.9M-7.56M-5.57M-4.14M-2.87M-4M1M-3.45M-3.45M-5.68M-5.18M-5.79M-1.45M-4.35M
Net Margin %--------------------
Net Income Growth %-290.15%-40.46%-121.07%74.93%33.44%8.84%-0.84%-88.95%-656.04%-20.09%16.68%29.58%119.34%40.47%-137.42%-30.68%11.34%15%-258.89%41.58%
Net Income (Continuing)-14.46M-5.3M-6.4M-1.9M-3.71M-3.77M-2.9M-7.56M-5.57M-4.14M-2.87M-4M1M-3.45M-3.45M-5.68M-5.18M-5.79M-1.45M-4.35M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-688.00-248.00-392.00-120.00-272.00-392.00-472.00-1608.00-1656.00-1880.00-1136.00-1584.00528.00-2016.00-2016.00-3832.00-3864.00-4856.00-1248.00-4520.00
EPS Growth %-152.94%36.73%16.95%92.54%83.57%79.15%58.45%-1.52%-413.64%6.75%43.65%58.66%113.66%58.48%-61.54%15.22%36.36%53.31%-215.56%52.92%
EPS (Basic)-688.00-248.00-392.00-120.00-272.00-392.00-472.00-1608.00-1656.00-1880.00-1136.00-1584.00528.00-2016.00-2016.00-3832.00-3864.00-4856.00-1248.00-4520.00
Diluted Shares Outstanding21.04K21.04K16.33K15.73K13.65K9.7K6.1K4.71K3.36K2.2K2.53K2.53K1.89K1.71K1.71K1.48K1.34K1.19K1.16K961
Basic Shares Outstanding21.04K21.04K16.33K15.74K13.65K9.7K6.1K4.71K3.36K2.2K2.53K2.53K1.89K1.71K1.71K1.48K1.34K1.19K1.16K961
Dividend Payout Ratio--------------------